Potential acceptance of HPV vaccination at ages 9–10 in the United States among parents of HPV vaccine-naïve children

Date
2025
Language
American English
Embargo Lift Date
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Taylor & Francis
Can't use the file because of accessibility barriers? Contact us with the title of the item, permanent link, and specifics of your accommodation need.
Abstract

This study explored attitudes/perceptions among parents who have not yet agreed to HPV vaccination for their 11-12-y-old children. US parents/guardians were recruited from a consumer panel for this online, cross-sectional survey. Parents (≥18 y) were eligible if their oldest child was 11-12, participated in their child's vaccine decisions/visit, had not decided on, or would refuse the HPV vaccine, and understood English. Parents were excluded if their child had medical conditions affecting eligibility for HPV vaccination or if they declined to provide consent. Sampling quotas were used for parent and child age, sex, and US region. Of 200 participants, half were undecided whether to accept HPV vaccination for their children and half planned to refuse (purposely targeted recruitment). Most participants were women (70%) and White (86%) with a mean age of 39 y. Significantly, more parents who planned to refuse reported delaying/refusing other vaccinations compared to undecided parents (57% vs 11%, p < .001). Undecided parents selected significantly different primary reasons for not vaccinating (p < .001); they were more concerned about side effects (42% vs 25%) and less worried it would encourage their children to be sexually active (9% vs 22%). Most parents in the undecided cohort reported they would definitely have accepted the HPV vaccination (52% vs 36%) if their child's provider had offered it when their child was younger, compared to parents who planned to refuse. Introducing HPV vaccine at an earlier age may be associated with increased parental acceptance specifically among those children who had not yet received HPV vaccination.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Saxena K, Dempsey A, Verma RP, Schmier JK, Kamat S, Zimet GD. Potential acceptance of HPV vaccination at ages 9-10 in the United States among parents of HPV vaccine-naïve children. Hum Vaccin Immunother. 2025;21(1):2578906. doi:10.1080/21645515.2025.2578906
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Human Vaccines & Immunotherapeutics
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}